Table of contents

Clinical and epidemiological research

• Extended report: Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review (22 December, 2008)

  G Ruiz-Irastorza, M Ramos-Casals, P Brito-Zeron, M A Khamashta
• Extended report: Lupus-specific health outcome measure for US patients: the LupusQoL-US version (6 January, 2009)

  M Jolly, A S Pickard, C Wilke, R A Mikolaitis, L-S Teh, K McElhone, L Fogg, J Block
• Extended report: Periodontal disease in patients with ankylosing spondylitis (6 January, 2009)

  N Pischon, T Pischon, E Gülmez, J Kröger, P Purucker, B-M Kleber, H Landau, P-G Jost-Brinkmann, P Schlattmann, J Zernicke, G-R Burmester, J-P Bernimoulin, F Buttgereit, J Detert
• Extended report: The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study (22 December, 2008)

  H G Raterman, I C van Eijk, A E Voskuyl, M J L Peters, B A C Dijkmans, V P van Halm, S Simsek, W F Lems, M T Nurmohamed
• Extended report: Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide (15 January, 2009)

  J R Curtis, T Beukelman, A Onofrei, S Cassell, J D Greenberg, A Kavanaugh, G Reed, V Strand, J M Kremer
• Extended report: Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment (15 January, 2009)

  L C Coates, J Fransen, P S Helliwell
• Extended report:

  Gene–environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis

  (16 January, 2009)

  E W Karlson, S-C Chang, J Cui, L B Chibnik, P A Fraser, I De Vivo, K H Costenbader
• Extended report: The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide (20 January, 2009)

  F A Houssiau, C Vasconcelos, D D’Cruz, G D Sebastiani, E de Ramon Garrido, M G Danieli, D Abramovicz, D Blockmans, A Cauli, H Direskeneli, M Galeazzi, A Gül, Y Levy, P Petera, R Popovic, R Petrovic, R A Sinico, R Cattaneo, J Font, G Depresseux, J-P Cosyns, R Cervera
• Extended report: DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis (20 January, 2009)

  Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, P J S M Kerstens, M M J Nielen, K Vos, D van Schaardenburg, I Speyer, P E H Seys, F C Breedveld, C F Allaart, B A C Dijkmans
• Extended report: Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies (27 January, 2009)

  D Sugiyama, K Nishimura, K Tamaki, G Tsuji, T Nakazawa, A Morinobu, S Kumagai
• Extended report: Does removal of aids/devices and help make a difference in the Childhood Health Assessment Questionnaire disability index? (16 February, 2009)

  C Saad-Magalhães, A Pistorio, A Ravelli, G Filocamo, S Viola, R Brik, D Mihaylova, R ten Cate, B Andersson-Gare, V Ferriani, K Minden, P Hashkes, M Rygg, M-J Sauvain, H Venning, A Martini, N Ruperto
• Extended report: Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study (17 March, 2009)

  G Jones, A Sebba, J Gu, M B Lowenstein, A Calvo, J J Gomez-Reino, D A Siri, M Tomšič, E Alecock, T Woodworth, M C Genovese
• Extended report: Measure of function in rheumatoid arthritis: individualised or classical scales? (2 April, 2009)

  R Seror, F Tubach, G Baron, F Guillemin, P Ravaud
• Extended report: ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health (11 March, 2009)

  A Boonen, J Braun, I E van der Horst Bruinsma, F Huang, W Maksymowych, N Kostanjsek, A Cieza, G Stucki, D van der Heijde
• Extended report: Role of contextual factors in health-related quality of life in ankylosing spondylitis (11 March, 2009)

  V S Gordeev, W P Maksymowych, S M A A Evers, A Ament, L Schachna, A Boonen
• Extended report: Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial (19 March, 2009)

  X Chevalier, J Jerosch, P Goupille, N van Dijk, F P Luyten, D L Scott, F Bailleul, K Pavelka
• Extended report: Short-term changes in magnetic resonance imaging and disease activity in response to infliximab (26 March, 2009)

  H M Bonel, C Boller, B Saar, S Tanner, S Srivastav, P M Villiger
• Extended report: Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry) (25 May, 2009)

  J Augustsson, M Neovius, C Cullinane-Carli, S Eksborg, R F van Vollenhoven
• Extended report:

  Cognitive function and ^99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjögren syndrome: a case–control study

  (21 January, 2009)

  V Le Guern, C Belin, C Henegar, C Moroni, D Maillet, C Lacau, J L Dumas, N Vigneron, L Guillevin
• Extended report: Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis (5 July, 2009)

  F H M Prince, L M Geerdink, G J J M Borsboom, M Twilt, M A J van Rossum, E P A H Hoppenreijs, R ten Cate, Y Koopman-Keemink, M van Santen-Hoeufft, H Raat, L W A van Suijlekom-Smit
• Extended report: Does cartilage volume or thickness distinguish knees with and without mild radiographic osteoarthritis? The Framingham Study (4 February, 2009)

  S Reichenbach, M Yang, F Eckstein, J Niu, D J Hunter, C E McLennan, A Guermazi, F Roemer, M Hudelmaier, P Aliabadi, D T Felson
• Extended report: Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis (18 December, 2008)

  H Berner Hammer, S Ødegård, S W Syversen, R Landewé, D van der Heijde, T Uhlig, P Mowinckel, T K Kvien
• Extended report: Change in regional cartilage morphology and joint space width in osteoarthritis participants versus healthy controls: a multicentre study using 3.0 Tesla MRI and Lyon–Schuss radiography (22 December, 2008)

  M-P Hellio Le Graverand, R J Buck, B T Wyman, E Vignon, S A Mazzuca, K D Brandt, M Piperno, H C Charles, M Hudelmaier, D J Hunter, C Jackson, V Byers Kraus, T M Link, S Majumdar, P V Prasad, T J Schnitzer, A Vaz, W Wirth, F Eckstein
• Extended report: High systemic bone mineral density increases the risk of incident knee OA and joint space narrowing, but not radiographic progression of existing knee OA: the MOST study (15 January, 2009)

  M C Nevitt, Y Zhang, M K Javaid, T Neogi, J R Curtis, J Niu, C E McCulloch, N A Segal, D T Felson
• Extended report: Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study (19 January, 2009)

  V Nell-Duxneuner, K Machold, T Stamm, G Eberl, H Heinzl, E Hoefler, J S Smolen, G Steiner
• Extended report: Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus (21 January, 2009)

  Y Molad, M Amit-Vasina, O Bloch, E Yona, M J Rapoport
• Extended report: Comparison of interferon γ release assays and conventional screening tests before tumour necrosis factor α blockade in patients with inflammatory arthritis (28 January, 2009)

  J Martin, C Walsh, A Gibbs, T McDonnell, U Fearon, J Keane, M B Codd, J Dodd, D Veale, O FitzGerald, B Bresnihan
• Concise report: The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3- and 6-month response rates in trials of biological agents (22 September, 2009) Free

  M Boers
• Concise report: Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study (22 December, 2008)

  V Smith, J T Van Praet, B Vandooren, B Van der Cruyssen, J-M Naeyaert, S Decuman, D Elewaut, F De Keyser
• Concise report: Distribution of joint involvement in women with hand osteoarthritis and associations between joint counts and patient-reported outcome measures (15 January, 2009)

  B Slatkowsky-Christensen, I Haugen, T K Kvien
• Concise report: Overlap of coronary disease and pulmonary arterial hypertension in systemic sclerosis (21 January, 2009)

  A Komócsi, T Pintér, R Faludi, B Magyari, J Bozó, G Kumánovics, T Minier, J Radics, L Czirják
• Concise report: Effect of adalimumab on joint disease: features of patients with psoriatic arthritis detected by magnetic resonance imaging (9 February, 2009)

  A P Anandarajah, P Ory, D Salonen, C Feng, R L Wong, C T Ritchlin
• Concise report: Role of European mitochondrial DNA haplogroups in the prevalence of hip osteoarthritis in Galicia, Northern Spain (17 February, 2009)

  I Rego, M Fernández-Moreno, C Fernández-López, J J Gómez-Reino, A González, J Arenas, F J Blanco
• Concise report: Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis (16 February, 2009)

  L Mouthon, C Mestre-Stanislas, A Bérezné, F Rannou, P Guilpain, M Revel, C Pagnoux, L Guillevin, J Fermanian, S Poiraudeau
• Concise report: Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis (10 March, 2009)

  Y Allanore, C Meune, M C Vonk, P Airo, E Hachulla, P Caramaschi, G Riemekasten, F Cozzi, L Beretta, C T Derk, A Komócsi, D Farge, A Balbir, V Riccieri, O Distler, A Chialà, N Del Papa, K Pasalic Simic, M Ghio, B Stamenkovic, S Rednic, N Host, R Pellerito, E Zegers, A Kahan, U A Walker, M Matucci-Cerinic
• Concise report: Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial (16 March, 2009)

  J Kekow, R J Moots, P Emery, P Durez, A Koenig, A Singh, R Pedersen, D Robertson, B Freundlich, R Sato
• Concise report: Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials (21 May, 2009)

  J Sieper, A Koenig, S Baumgartner, C Wishneski, J Foehl, B Vlahos, B Freundlich
• Concise report: Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage (21 January, 2009)

  M Ahlmén, B Svensson, K Albertsson, K Forslind, I Hafström
• Concise report: TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade (15 January, 2009)

  A W R van Kuijk, C A Wijbrandts, M Vinkenoog, T S Zheng, K A Reedquist, P P Tak